RMD 0.54% $37.28 resmed inc

Chill out and buy more massive opportunity for the long term now...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,050 Posts.
    lightbulb Created with Sketch. 1
    Chill out and buy more massive opportunity for the long term now

    What's changed
    We mark to market RMD’s hedge book for the March quarter. We expect a
    modest hedge book gain, driven by the strengthening of the Australian
    Dollar against the Euro. As with the December quarter the AUD has
    depreciated significantly against the USD; however, RMD’s AUDUSD FX
    hedge exposure through the P&L remains almost fully offset by balance
    sheet hedging. Also, our recent channel checks suggest that RMD has
    strengthened its market position in the US through longer-term
    commitments in response to DMEs seeking greater certainty over their
    input costs. We also believe the industry is seeing strong growth in some
    of the higher value niche segments.
    Implications
    We believe RMD currently has strong momentum in local currency sales in
    both the US and Rest of World, albeit that flow gens are likely to be
    outpacing masks. FX headwinds will, however, drag on reported earnings
    growth into FY16, in our view.
    Valuation
    We take the opportunity to incorporate recent updated FX forecasts from
    the Goldman Sachs Macro team, in particular a materially stronger
    USDEUR in FY16E. The resulting downgrades are partly offset by
    improved revenue forecasts in US flow gens in FY16 and beyond. We also
    incorporate a $2mn hedge book gain for 3Q15. Overall, we downgrade our
    FY15-FY17 EPS assumptions by 0.2%-5.0%. We raise our 12-month price
    target by 7% to A$9.20 (based on 22x 1-year forward P/E at spot FX,
    unchanged) which reflects a lower AUD, higher US flow gen revenues, and
    a roll-forward to FY17E metrics. There is no change to our Buy rating.
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.28
Change
0.200(0.54%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.50 $37.55 $37.15 $17.93M 480.5K

Buyers (Bids)

No. Vol. Price($)
1 3363 $37.27
 

Sellers (Offers)

Price($) Vol. No.
$37.30 1001 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.